Pharma

Aug 27, 2015 at 21:58 | Source: CNBC-TV18
While tech major Infosys has decided to bring in a new person to head its human resource development department, Dr Reddy's has been forced to rejig its top deck after its rival Cipla poached the pharma major's North America business head.
Aug 27, 2015 at 21:17 | Source: CNBC-TV18
The pharma major's MD and CEO Subhanu Saxena says the company is aiming at achieving a growth of 70-80 percent growth without making any major acquisitions in the near future.
Aug 27, 2015 at 18:01 | Source: PTI
The company has received final approval for its Omeprazole delayed-release capsules (40 mg) from the United States Food and Drugs Administration (USFDA), Lupin Ltd said in a statement.
Aug 27, 2015 at 16:32 | Source: CNBC-TV18
Dipan Mehta, Member at BSE & NSE is of the view that one may look at pharmaceutical, private sector banks and the IT space.
Aug 27, 2015 at 13:39 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Entecavir tablets in strengths of 0.5mg and 1mg, Aurobindo Pharma said in a statement.
Aug 27, 2015 at 13:28 | Source: Moneycontrol.com
"The company has received the final approval from the USFDA to manufacture and market Entecavir Tablets, 0.5mg and 1mg," it said in a filing to the exchange.
Aug 27, 2015 at 13:12 | Source: Moneycontrol.com
Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Entecavir Tablets, 0.5mg and 1mg (ANDA 206217).
Aug 27, 2015 at 11:00 | Source: Moneycontrol.com
HDFC, Vedanta, Lupin, Cipla and Tata Steel are top gainers while BHEL, Bajaj Auto, Hero MotoCorp, Coal India and TCS are among laggards.
Aug 27, 2015 at 10:25 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Divis Laboratories and Wockhardt and adding Aurobindo Pharma.
Aug 27, 2015 at 09:47 | Source: CNBC-TV18
There is a realization that world will grow at a much slower pace and markets are adjusting to that. Yuan devaluation led to that realization since China has been the world's growth engine, said independent market expert Jyotivardhan Jaipuria.
Messages on Pharma »

subs74

Silver Member

4 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th 2014

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th 2014

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th 2014

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th 2014

jagoinvesto
r

Platinum Member

121 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th 2014

JPInvestor

New Member

1 Followers

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th 2014

shmarketgen
ius

Platinum Member

689 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th 2014

countryman

Platinum Member

929 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th 2014

News across the web »
Jul 28, 2015 at 02:15 | Source: FirstPost
Jul 28, 2015 at 00:45 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.